Compugen (CGEN) Revenue (QoQ) (2009 - 2026)
Compugen (CGEN) Revenue (QoQ) (2009 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Compugen |
189.59 Mn |
97.83 Mn |
352,000.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
-96.77% |
| Dec 31, 2025 |
3,460.66% |
| Sep 30, 2025 |
50.44% |
| Jun 30, 2025 |
-44.96% |
| Mar 31, 2025 |
55.27% |
| Dec 31, 2024 |
-91.41% |
| Sep 30, 2024 |
155.63% |
| Jun 30, 2024 |
161.90% |
| Mar 31, 2024 |
-92.35% |
| Dec 31, 2016 |
75,714,185.71% |
| Sep 30, 2016 |
-85.89% |
| Jun 30, 2016 |
433.33% |
| Mar 31, 2016 |
-98.88% |
| Dec 31, 2015 |
3,530.13% |
| Sep 30, 2015 |
2.69% |
| Jun 30, 2015 |
-56.53% |
| Mar 31, 2015 |
-92.17% |
| Dec 31, 2014 |
281.37% |
| Sep 30, 2014 |
-12.53% |
| Jun 30, 2014 |
-7.92% |
